Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Oncology GmbH
FDA Inspection
•Baxter Oncology GmbH•March 18, 2016

Baxter Oncology GmbH – FDA Inspection, Mar 18, 2016

Record Details

This FDA Inspection record concerns Baxter Oncology GmbH, with an inspection on March 18, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Baxter Oncology GmbH
Inspection Date
March 18, 2016
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · cee1839e-90d4-436f-a2f1-187376c7dc5a

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
967376
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

7
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.46(b)Equipment for Environmental Control
  4. 21 CFR 211.113(b)Validation lacking for sterile drug products
  5. 21 CFR 211.28(b)Habits of good sanitation & health
  6. 21 CFR 211.42(b)Product flow through building is inadequate
  7. 21 CFR 211.192Written record of investigation incomplete

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Oncology GmbH

11
DateClassificationOfficeProject area
September 26, 2025OAIOffice of Inspections and InvestigationsDrug Quality Assurance
August 27, 2024Not classifiedOffice of Inspections and Investigations
May 3, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 29, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 3, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page
Other documents for Baxter Oncology GmbH
  • FDA Inspection 1283802 - 2025-09-26
  • FDA Inspection 1249702 - 2024-08-27
  • FDA Inspection 1206312 - 2023-05-03
  • FDA Inspection 1161093 - 2020-01-29
  • FDA Inspection 1106642 - 2019-09-03

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Oncology GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.